Monkey Pox Becomes a Global Threat: Is India at Risk and What Is the Current Status?

Monkey Pox Becomes a Global Threat: Is India at Risk and What Is the Current Status?

                Synopsis: India is monitoring the Mpox situation closely after the World Health Organization's declaration of the disease as a public health emergency. Despite the global rise in cases, particularly in Africa and Europe, Indian officials report a low risk of an outbreak. The government has enhanced surveillance and testing measures, with no new cases since March 2024.

The Global Threat of Monkey Pox and Its Impact on India

Monkey Pox, now officially referred to as Mpox, has evolved into a global health threat. The World Health Organization (WHO) has declared Mpox a public health emergency of international concern (PHEIC), a move that highlights the severity of the situation worldwide. As the virus spreads across continents, particularly in Africa and Europe, many are asking, “Is India at risk?” The situation is undoubtedly serious, but Indian health authorities are keen to reassure the public that the risk of a large-scale Mpox outbreak within the country remains minimal.

Current Mpox Situation in India

As of now, the Mpox situation in India seems to be under control. The last reported case was in March 2024, originating from Kerala. Since the outbreak began in 2022, India has recorded a total of 30 confirmed Mpox cases. This relatively low number has been a source of cautious optimism for Indian officials. Despite the global rise in Mpox cases, particularly in Africa and Europe, the Indian government believes that the threat level within the country is low. According to a statement from an official source, “At the moment, the risk of a surge in monkeypox infection is very low in India, and there is no need to panic.”

Government Actions and Measures

In response to the WHO’s declaration and the rising number of Mpox cases globally, India is taking several precautionary measures. The health ministry is expected to issue advisories for increased vigilance at international entry points such as airports and seaports. These advisories will guide these locations on managing suspected Mpox cases in line with existing protocols, which include isolation and treatment guidelines.

Union Health Minister Jagat Prakash Nadda is scheduled to meet with officials from the Ministry of Health, the National Centre for Disease Control (NCDC), and the Indian Council of Medical Research (ICMR) to review the situation. The meeting will focus on reinforcing necessary precautions to prevent the virus from gaining a foothold in India. Additionally, the Ministry of Health has designated three Centre-run hospitals in Delhi—Ram Manohar Lohia Hospital, Safdarjung Hospital, and Lady Hardinge Medical College—as key facilities for managing Mpox cases.

Global Context and Surveillance

The global surge in Mpox cases has led to increased alert levels in several countries, particularly in Europe. The European Centre for Disease Prevention and Control (ECDC) has raised its risk assessment to “moderate” due to the emergence of a new strain in Sweden. This development has caused concern worldwide, but the WHO has advised against imposing travel restrictions, opting instead to focus on enhanced surveillance and public health measures.

In light of the global situation, the Indian Health Ministry has directed all airports and border authorities to remain vigilant for international passengers showing symptoms of Mpox. Surveillance efforts have been intensified, and a network of 32 testing laboratories across the country has been set up for early diagnosis. This proactive approach is crucial in ensuring that any potential outbreak is contained swiftly.

Current Assessment of Mpox in India

Despite the alarming rise in Mpox cases globally, India remains relatively unaffected, with no new cases reported since March 2024. Health officials maintain that the risk of a large-scale outbreak in India is low. The Health Ministry’s primary focus is on enhancing surveillance and ensuring that healthcare providers are well-informed about the symptoms and protocols related to Mpox.

The WHO’s global statistics on Mpox are concerning. Since 2022, there have been 99,176 Mpox cases and 208 deaths reported from 116 countries. The number of cases and deaths has increased significantly in 2024, with over 15,600 cases and 537 deaths reported so far. These figures underline the importance of remaining vigilant and prepared, even in countries like India, where the current risk is considered low.

Staying Vigilant Against the Mpox Threat

The declaration of Mpox as a public health emergency by the WHO is a stark reminder of the ever-present threat of infectious diseases in our globalised world. While India currently faces a low risk of a significant Mpox outbreak, the government’s proactive measures and enhanced surveillance are essential in maintaining this status.

As the global Mpox situation evolves, it is crucial for Indian health authorities and the public to remain vigilant. The steps taken by the Indian government, including heightened surveillance, increased testing capacity, and designated treatment centres, are all part of a comprehensive strategy to prevent the spread of Mpox within the country.

The question, “Is India at risk?” is one that will continue to be asked as long as Mpox remains a threat globally. However, with the current measures in place and the continued vigilance of health authorities, India is well-positioned to keep the risk of Mpox at bay.

In the face of this global threat, it is essential that we remain informed and prepared, understanding that while the situation in India is under control for now, the rapidly changing nature of infectious diseases requires ongoing attention and action.